Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK's Launches, Global Expansion Drive Consumer Sales Ahead Of Market

This article was originally published in The Tan Sheet

Executive Summary

Brand innovation, continued investment in marketing and global expansion help drive up GlaxoSmithKline's consumer health care sales significantly faster than overall market growth, the firm says
Advertisement

Related Content

Glaxo's Stiefel Labs Touts Penetrating Foam In MaxClarity Acne Treatment
Glaxo's Stiefel Labs Touts Penetrating Foam In MaxClarity Acne Treatment
Glaxo's Stiefel Labs Touts Penetrating Foam In MaxClarity Acne Treatment
Sales & Earnings In Brief
Sales & Earnings In Brief
GSK Expands Consumer Business With Acquisition Of OTC Cold Sore Products
GSK Expands In Korea With Purchase Of Equity Stake In Dong-A Pharma
Alli hits European stores
Glaxo Augments OTCs With Stiefel Deal, Gains Strong Dermatology Foothold
With Biotene Acquisition, Glaxo Tries Again In Dry Mouth Category

Topics

Advertisement
UsernamePublicRestriction

Register

PS104068

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel